Pharmadrug Stock Technical Analysis
| LMLLF Stock | USD 0.01 0.0005 7.25% |
As of the 27th of February, Pharmadrug holds the Risk Adjusted Performance of 0.0508, semi deviation of 14.15, and Coefficient Of Variation of 1846.45. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmadrug, as well as the relationship between them. Please check Pharmadrug coefficient of variation and the relationship between the jensen alpha and skewness to decide if Pharmadrug is priced some-what accurately, providing market reflects its current price of 0.0074 per share. As Pharmadrug appears to be a penny stock we also advise to check out its total risk alpha numbers.
Pharmadrug Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pharmadrug, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PharmadrugPharmadrug |
Pharmadrug 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmadrug's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmadrug.
| 11/29/2025 |
| 02/27/2026 |
If you would invest 0.00 in Pharmadrug on November 29, 2025 and sell it all today you would earn a total of 0.00 from holding Pharmadrug or generate 0.0% return on investment in Pharmadrug over 90 days. Pharmadrug Inc. operates as a specialty pharmaceutical company More
Pharmadrug Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmadrug's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmadrug upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 26.1 | |||
| Information Ratio | 0.047 | |||
| Maximum Drawdown | 86.01 | |||
| Value At Risk | (30.84) | |||
| Potential Upside | 29.73 |
Pharmadrug Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmadrug's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmadrug's standard deviation. In reality, there are many statistical measures that can use Pharmadrug historical prices to predict the future Pharmadrug's volatility.| Risk Adjusted Performance | 0.0508 | |||
| Jensen Alpha | 0.6283 | |||
| Total Risk Alpha | (1.60) | |||
| Sortino Ratio | 0.0307 | |||
| Treynor Ratio | 0.3593 |
Pharmadrug February 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0508 | |||
| Market Risk Adjusted Performance | 0.3693 | |||
| Mean Deviation | 10.71 | |||
| Semi Deviation | 14.15 | |||
| Downside Deviation | 26.1 | |||
| Coefficient Of Variation | 1846.45 | |||
| Standard Deviation | 17.05 | |||
| Variance | 290.79 | |||
| Information Ratio | 0.047 | |||
| Jensen Alpha | 0.6283 | |||
| Total Risk Alpha | (1.60) | |||
| Sortino Ratio | 0.0307 | |||
| Treynor Ratio | 0.3593 | |||
| Maximum Drawdown | 86.01 | |||
| Value At Risk | (30.84) | |||
| Potential Upside | 29.73 | |||
| Downside Variance | 681.34 | |||
| Semi Variance | 200.36 | |||
| Expected Short fall | (17.76) | |||
| Skewness | (0.04) | |||
| Kurtosis | 1.45 |
Pharmadrug Backtested Returns
Pharmadrug appears to be out of control, given 3 months investment horizon. Pharmadrug maintains Sharpe Ratio (i.e., Efficiency) of 0.044, which implies the firm had a 0.044 % return per unit of risk over the last 3 months. By analyzing Pharmadrug's technical indicators, you can evaluate if the expected return of 0.78% is justified by implied risk. Please evaluate Pharmadrug's Semi Deviation of 14.15, coefficient of variation of 1846.45, and Risk Adjusted Performance of 0.0508 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pharmadrug holds a performance score of 3. The company holds a Beta of 2.54, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pharmadrug will likely underperform. Please check Pharmadrug's potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether Pharmadrug's historical price patterns will revert.
Auto-correlation | 0.15 |
Insignificant predictability
Pharmadrug has insignificant predictability. Overlapping area represents the amount of predictability between Pharmadrug time series from 29th of November 2025 to 13th of January 2026 and 13th of January 2026 to 27th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmadrug price movement. The serial correlation of 0.15 indicates that less than 15.0% of current Pharmadrug price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.15 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pharmadrug technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Pharmadrug Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Pharmadrug across different markets.
About Pharmadrug Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pharmadrug on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pharmadrug based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pharmadrug price pattern first instead of the macroeconomic environment surrounding Pharmadrug. By analyzing Pharmadrug's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pharmadrug's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pharmadrug specific price patterns or momentum indicators. Please read more on our technical analysis page.
Pharmadrug February 27, 2026 Technical Indicators
Most technical analysis of Pharmadrug help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pharmadrug from various momentum indicators to cycle indicators. When you analyze Pharmadrug charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0508 | |||
| Market Risk Adjusted Performance | 0.3693 | |||
| Mean Deviation | 10.71 | |||
| Semi Deviation | 14.15 | |||
| Downside Deviation | 26.1 | |||
| Coefficient Of Variation | 1846.45 | |||
| Standard Deviation | 17.05 | |||
| Variance | 290.79 | |||
| Information Ratio | 0.047 | |||
| Jensen Alpha | 0.6283 | |||
| Total Risk Alpha | (1.60) | |||
| Sortino Ratio | 0.0307 | |||
| Treynor Ratio | 0.3593 | |||
| Maximum Drawdown | 86.01 | |||
| Value At Risk | (30.84) | |||
| Potential Upside | 29.73 | |||
| Downside Variance | 681.34 | |||
| Semi Variance | 200.36 | |||
| Expected Short fall | (17.76) | |||
| Skewness | (0.04) | |||
| Kurtosis | 1.45 |
Pharmadrug February 27, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Pharmadrug stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 14,878 | ||
| Daily Balance Of Power | 0.11 | ||
| Rate Of Daily Change | 1.07 | ||
| Day Median Price | 0.01 | ||
| Day Typical Price | 0.01 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Pharmadrug Pink Sheet analysis
When running Pharmadrug's price analysis, check to measure Pharmadrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmadrug is operating at the current time. Most of Pharmadrug's value examination focuses on studying past and present price action to predict the probability of Pharmadrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmadrug's price. Additionally, you may evaluate how the addition of Pharmadrug to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |